Compositions and Methods for Pairwise Sequencing
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 63/212,059, filed Jun 17, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,220,707 | Compositions and Methods for Pairwise Sequencing In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| US 11,859,241 | Compositions and Methods for Pairwise Sequencing In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| US 11,891,651 | Compositions and Methods for Pairwise Sequencing In force · High confidence | Element Biosciences, Inc. | In force | High confidence | ||
| Application 18/510,487 | Compositions and Methods for Pairwise Sequencing Pending Not granted | Element Biosciences, Inc. | Pending | Not granted | ||
| Application 18/544,085 | Compositions and Methods for Pairwise Sequencing Abandoned Abandoned Sep 9, 2024 | Element Biosciences, Inc. | Abandoned | Abandoned Sep 9, 2024 | ||
| Application 18/824,527 | Compositions and Methods for Pairwise Sequencing Pending Not granted | Element Biosciences, Inc. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Element Biosciences, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.